Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;48(1):e70076.
doi: 10.1002/clc.70076.

Impact of Standardized Heart Failure Management Center Construction on the Management of Patients With Chronic Heart Failure

Xiaoxia Guo  1 , Lele Jing  1 , Changlin Zhai  1 , Liang Shen  1 , Huilin Hu  1
Affiliations

Impact of Standardized Heart Failure Management Center Construction on the Management of Patients With Chronic Heart Failure

Xiaoxia Guo et al. Clin Cardiol. 2025 Jan.

Abstract

Background: Heart failure is extremely harmful to human health and social economics. The purpose of standardized heart failure management center (SHFMC) is to correct the non-standardization of heart failure treatment.

Hypothesis: SHFMC has a positive impact on the management and prognosis of patients with chronic heart failure (CHF).

Methods: The SHFMC database of Jiaxing First Hospital was retrospectively analyzed. Two hundred sixty-three patients with CHF who were hospitalized in the cardiovascular medicine department of Jiaxing First Hospital in Zhejiang Province from January 2020 to December 2020 were identified as study subjects. The SHFMC opening day, July 1, 2020, was used as the dividing line around which the patients were divided into Group A (before the completion of SHFMC, n = 137) and Group B (after, n = 126). The baseline data, treatment standardization, long-term efficacy, 1-year all-cause mortality, and readmission rate of the two groups were compared.

Results: The use of angiotensin receptor enkephalinase inhibitors (ARNIs), β-blockers (β-Bs), and sodium-glucose cotransport protein 2 inhibitors (SGLT2is) increased significantly, and the long-term outcome, readmission rate, and 1-year all-cause mortality of patients improved in group B.

Conclusions: The construction of SHFMC has been associated with consistent improvements in the standardization of CHF treatment, long-term patient outcomes, 1-year cumulative survival rates, and readmission rates.

Keywords: chronic heart failure; readmission rate; sodium‐glucose cotransport protein 2 inhibitors; standardized heart failure management center; treatment standardization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Etiologies of CHF (distribution of causes).
Figure 2
Figure 2
Comparison of utilization rates of different CHF drugs. ARNIs, β‐Bs, SGLT2is, ACEIs/ARBs, diuretics, spironolactone, digoxin. *p < 0.05.
Figure 3
Figure 3
Kaplan–Meier curves for cumulative HF survival.
See this image and copyright information in PMC

References

    1. Heidenreich P. A., Bozkurt B., Aguilar D., et al., “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary,” Journal of the American College of Cardiology 79 (2022): 1757–1780, 10.1016/j.jacc.2021.12.011. - DOI - PubMed
    1. Savarese G., Becher P. M., Lund L. H., Seferovic P., Rosano G. M. C., and Coats A. J. S., “Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology,” Cardiovascular Research 118 (2023): 3272–3287, 10.1093/cvr/cvac013. - DOI - PubMed
    1. Emmons‐Bell S., Johnson C., and Roth G., “Prevalence, Incidence and Survival of Heart Failure: A Systematic Review,” Heart 108 (2022): 1351–1360, 10.1136/heartjnl-2021-320131. - DOI - PMC - PubMed
    1. James S. L., Abate D., Abate K. H., et al., “Gbd 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017,” The Lancet 392 (2018): 1789–1858, 10.1016/s0140-6736(18)32279-7. - DOI - PMC - PubMed
    1. Zhang Y., Gao C., Greene S. J., et al., “Clinical Performance and Quality Measures for Heart Failure Management in China: The China‐Heart Failure Registry Study,” ESC Heart Failure 10 (2023): 342–352, 10.1002/ehf2.14184. - DOI - PMC - PubMed

LinkOut - more resources